Cargando…

Fibroblast growth factor 23 and symmetric dimethylarginine concentrations in geriatric cats

BACKGROUND: Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that is increased in azotemic cats with chronic kidney disease (CKD) and predictive of the onset of azotemia in older cats. The introduction of symmetric dimethylarginine (SDMA) as a biomarker of glomerular filtration rate has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sargent, Hannah J., Jepson, Rosanne E., Chang, Yu‐mei, Biourge, Vincent C., Bijsmans, Esther S., Elliott, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872607/ https://www.ncbi.nlm.nih.gov/pubmed/31568615 http://dx.doi.org/10.1111/jvim.15590

Ejemplares similares

Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus
por: Langhorn, R., et al.
Publicado: (2017)

The effect of attenuating dietary phosphate restriction on blood ionized calcium concentrations in cats with chronic kidney disease and ionized hypercalcemia
por: Geddes, Rebecca F., et al.
Publicado: (2021)

Risk factors associated with disturbances of calcium homeostasis after initiation of a phosphate‐restricted diet in cats with chronic kidney disease
por: Tang, Pak‐Kan, et al.
Publicado: (2020)

Evaluation of Serum Symmetric Dimethylarginine Concentration as a Marker for Masked Chronic Kidney Disease in Cats With Hyperthyroidism
por: Peterson, M.E., et al.
Publicado: (2018)

Plasma symmetric dimethylarginine and creatinine concentrations and glomerular filtration rate in cats with normal and decreased renal function
por: Brans, Marleen, et al.
Publicado: (2020)

Evaluation of symmetric dimethylarginine in cats with acute kidney injury and chronic kidney disease
por: Loane, Samantha C., et al.
Publicado: (2022)

Assessment of symmetric dimethylarginine as a biomarker of renal function in hyperthyroid cats treated with radioiodine
por: Buresova, Eva, et al.
Publicado: (2019)

Psychometric Validation of a General Health Quality of Life Tool for Cats Used to Compare Healthy Cats and Cats with Chronic Kidney Disease
por: Bijsmans, E.S., et al.
Publicado: (2016)

Assessment of serum symmetric dimethylarginine and creatinine concentrations in hyperthyroid cats before and after a fixed dose of orally administered radioiodine
por: Yu, Lucia, et al.
Publicado: (2020)

Effect of storage temperature and time on measurement of serum symmetric dimethylarginine concentration using point‐of‐care and commercial laboratory analyzers in cats and dogs
por: Brans, Marleen, et al.
Publicado: (2023)

Variability of Symmetric Dimethylarginine in Apparently Healthy Dogs
por: Kopke, M.A., et al.
Publicado: (2018)

Plasma Symmetric Dimethylarginine Concentration in Dogs with Acute Kidney Injury and Chronic Kidney Disease
por: Dahlem, D.P., et al.
Publicado: (2017)

Serum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney Disease
por: Hall, J.A., et al.
Publicado: (2016)

Clinical progression of cats with early‐stage chronic kidney disease fed diets with varying protein and phosphorus contents and calcium to phosphorus ratios
por: Schauf, Sofia, et al.
Publicado: (2021)

Plasma N‐Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats
por: Bijsmans, E.S., et al.
Publicado: (2017)

Factors Influencing the Relationship Between the Dose of Amlodipine Required for Blood Pressure Control and Change in Blood Pressure in Hypertensive Cats
por: Bijsmans, E.S., et al.
Publicado: (2016)

Relationship between Plasma Fibroblast Growth Factor‐23 Concentration and Survival Time in Cats with Chronic Kidney Disease
por: Geddes, R.F., et al.
Publicado: (2015)

Comparison of the diagnostic value of symmetric dimethylarginine, cystatin C, and creatinine for detection of decreased glomerular filtration rate in dogs
por: Pelander, Lena, et al.
Publicado: (2019)

Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis
por: Le Sueur, André Nanny Vieira, et al.
Publicado: (2019)

Development and validation of a multivariate predictive model to estimate serum ionized calcium concentration from serum biochemical profile results in cats
por: Hodgson, Natasha, et al.
Publicado: (2019)

Relationship between serum iohexol clearance, serum SDMA concentration, and serum creatinine concentration in non‐azotemic dogs
por: McKenna, Myles, et al.
Publicado: (2019)

Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease
por: van den Broek, D. Hendrik N., et al.
Publicado: (2018)

Risk factors and implications associated with renal mineralization in chronic kidney disease in cats
por: Tang, Pak‐Kan, et al.
Publicado: (2022)

An artificial neural network‐based model to predict chronic kidney disease in aged cats
por: Biourge, Vincent, et al.
Publicado: (2020)

Ionized hypercalcemia in cats with azotemic chronic kidney disease (2012‐2018)
por: van den Broek, Dirk Hendrik Nicolaas, et al.
Publicado: (2022)

Symmetric Dimethylarginine Assay Validation, Stability, and Evaluation as a Marker for the Early Detection of Chronic Kidney Disease in Dogs
por: Nabity, M.B., et al.
Publicado: (2015)

The association of bacteriuria with survival and disease progression in cats with azotemic chronic kidney disease
por: Hindar, Camilla, et al.
Publicado: (2020)

The Effect of Moderate Dietary Protein and Phosphate Restriction on Calcium‐Phosphate Homeostasis in Healthy Older Cats
por: Geddes, R.F., et al.
Publicado: (2016)

Effect of withholding food versus feeding on creatinine, symmetric dimethylarginine, cholesterol, triglycerides, and other biochemical analytes in 100 healthy dogs
por: Yi, Katarina C., et al.
Publicado: (2023)

The association of indoxyl sulfate with fibroblast growth factor‐23 in cats with chronic kidney disease
por: Liao, Yu‐Lun, et al.
Publicado: (2019)

Fibroblast Growth Factor‐23 Concentration in Dogs with Chronic Kidney Disease
por: Harjes, L.M., et al.
Publicado: (2017)

Chronic Kidney Disease in Cats and the Risk of Total Hypercalcemia
por: van den Broek, D.H.N., et al.
Publicado: (2017)

Selective symmetrical necrotizing encephalopathy secondary to primary mitochondrial disorder in a cat
por: Dell'Era, Elena, et al.
Publicado: (2021)

Clinical utility of estimation of glomerular filtration rate in dogs
por: McKenna, Myles, et al.
Publicado: (2019)

Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease
por: Williams, T.L., et al.
Publicado: (2016)

Calcitonin Response to Naturally Occurring Ionized Hypercalcemia in Cats with Chronic Kidney Disease
por: van den Broek, D.H.N., et al.
Publicado: (2018)

Evaluation of asymmetric dimethylarginine as an inflammatory and prognostic marker in dogs with acute pancreatitis
por: Gori, Eleonora, et al.
Publicado: (2020)

Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease
por: Miyakawa, Hirosumi, et al.
Publicado: (2021)

Evaluation of urine concentrations of amoxicillin and clavulanate in cats
por: KuKanich, Kate, et al.
Publicado: (2020)

Detection and seroprevalence of morbillivirus and other paramyxoviruses in geriatric cats with and without evidence of azotemic chronic kidney disease
por: McCallum, Katie Elizabeth, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4ubqhl45fg910c9o9g1bjh3hgm